1417 related articles for article (PubMed ID: 19376402)
41. Liver transplantation using livers from septuagenarian and octogenarian donors: an underused strategy to reduce mortality on the waiting list.
Pirenne J; Monbaliu D; Van Gelder F; Van Hees D; Aerts R; Verslype C; Van Steenbergen W; Ferdinande P; Fevery J; Nevens F; Coosemans W; Stockman W; Lormans P
Transplant Proc; 2005 Mar; 37(2):1180-1. PubMed ID: 15848662
[TBL] [Abstract][Full Text] [Related]
42. Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
Doyle MB; Anderson CD; Vachharajani N; Lowell JA; Shenoy S; Lisker-Melman M; Korenblat K; Crippin JS; Chapman WC
Arch Surg; 2008 Jul; 143(7):679-85; discussion 685. PubMed ID: 18645111
[TBL] [Abstract][Full Text] [Related]
43. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
44. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
45. The utility of marginal donors in liver transplantation.
Busuttil RW; Tanaka K
Liver Transpl; 2003 Jul; 9(7):651-63. PubMed ID: 12827549
[TBL] [Abstract][Full Text] [Related]
46. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
[TBL] [Abstract][Full Text] [Related]
47. The use of marginal grafts in liver transplantation.
Hashimoto K; Miller C
J Hepatobiliary Pancreat Surg; 2008; 15(2):92-101. PubMed ID: 18392701
[TBL] [Abstract][Full Text] [Related]
48. Can the use of marginal liver donors change recipient survival rate?
Rocha MB; Boin IF; Escanhoela CA; Leonardi LS
Transplant Proc; 2004 May; 36(4):914-5. PubMed ID: 15194314
[TBL] [Abstract][Full Text] [Related]
49. Analysis of survival after liver transplantation in Galicia, Spain.
Otero-Raviña F; Rodríguez-Martínez M; Sellés CF; Gutiérrez MG; Blanco MD; de Rituerto ST; Pérez EV; González-Juanatey JR; Sánchez-Guisande Jack D
Transplant Proc; 2005 Nov; 37(9):3913-5. PubMed ID: 16386582
[TBL] [Abstract][Full Text] [Related]
50. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
[TBL] [Abstract][Full Text] [Related]
51. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
[TBL] [Abstract][Full Text] [Related]
52. [How can the number of liver transplantations be increased?].
Fondevila C; Jiménez-Galanes S; García-Valdecasas JC
Gastroenterol Hepatol; 2009; 32(7):519-30. PubMed ID: 19608299
[TBL] [Abstract][Full Text] [Related]
53. Birmingham liver unit: use of marginal donors for liver transplantation.
Starkey G; Buckels J
Clin Transpl; 2008; ():137-42. PubMed ID: 19708452
[TBL] [Abstract][Full Text] [Related]
54. Suspect the donor with potential infection in the adult deceased donor liver transplantation.
Wu TJ; Lee CF; Chou HS; Yu MC; Lee WC
Transplant Proc; 2008 Oct; 40(8):2486-8. PubMed ID: 18929774
[TBL] [Abstract][Full Text] [Related]
55. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
56. Impact of different cadaveric donor age cut-offs on adult recipient survival after liver transplantation: a single-center analysis.
Santori G; Andorno E; Morelli N; Bottino G; Mondello R; Gianelli Castiglione A; Valente U
Transplant Proc; 2005; 37(6):2576-81. PubMed ID: 16182749
[TBL] [Abstract][Full Text] [Related]
57. Use of hepatitis C virus-positive grafts in liver transplantation: a single-centre experience.
Ricchiuti A; Brunati A; Mirabella S; Pierini A; Franchello A; Salizzoni M
Transplant Proc; 2005; 37(6):2569-70. PubMed ID: 16182746
[TBL] [Abstract][Full Text] [Related]
58. Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?
Decoster EL; Troisi R; Sainz-Barriga M; Haentjens I; Colenbie L; Geerts A; Colle I; Van Vlierberghe H; de Hemptinne B; Rogiers X
Transplant Proc; 2009 Oct; 41(8):3403-6. PubMed ID: 19857758
[TBL] [Abstract][Full Text] [Related]
59. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
Humar A; Beissel J; Crotteau S; Kandaswamy R; Lake J; Payne W
Transplantation; 2008 May; 85(10):1420-4. PubMed ID: 18497681
[TBL] [Abstract][Full Text] [Related]
60. Rescue allocation for liver transplantation within Eurotransplant: the Heidelberg experience.
Schemmer P; Nickkholgh A; Gerling T; Weitz J; Büchler MW; Schmidt J
Clin Transplant; 2009 Dec; 23 Suppl 21():42-8. PubMed ID: 19930316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
